CKD Bio Corp.

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band C with a total score of 41 points.

How grades are computed →What grades do and don’t mean →What the grade does not reflect →

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

Upper percentile

Top 16.4% in sector — P/B (price-to-book)Price attractiveness →

Lower percentile

Bottom 14% in sector — Operating income change (YoY)Growth momentum →Bottom 15.2% in sector — Debt-to-equity ratioFinancial strength →Bottom 19.6% in sector — Current ratioFinancial strength →

1-year closing price

Low ₩12,200High ₩24,500

Latest close

Price change by period

3.00%

6.50%

15.10%

39.30%

As of the Sep 2, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

Financial strength

37.1/100

How much debt does it carry relative to equity?

136.0%

Sector median 51.6%

Sector low

highBottom 15.2% in sector

Can it cover what's due within a year?

89.6%

Sector median 191.7%

Sector low

highBottom 19.6% in sector

How much of revenue becomes profit?

2.3%

Sector median -2.4%

Sector low

highTop 40% in sector

How much did it earn on its own capital?

-2.3%

Sector median -4.5%

Sector low

highTop 46.4% in sector

Source filing: annual report (separate) — view original ↗

Growth momentum

18.7/100

How much did revenue grow in a year?

-6.8%

Sector median 6.4%

Sector low

highBottom 23.4% in sector

Did core profits grow in a year?

-67.1%

Sector median 3.6%

Sector low

highBottom 14% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (separate) — view original ↗

Price attractiveness

61.8/100

Is the price expensive relative to earnings?

Loss-making (P/E not computable)

Sector median P/E of profitable peers 16.3x · 58% loss-making

Sector low

highBottom 39.9% in sector

Is the price expensive relative to book value?

0.61x

Sector median 1.61x

Sector low

highTop 16.4% in sector

Valuation uses the Sep 2, 2026 close and market cap

Shareholder Return

Single-indicator axis37.5/100

Does the company actually pay dividends?

0.0%

Sector median 0.0%

Sector low

highBottom 37.5% in sector

Dividend per share (annual)

Cash dividend per common share as stated in annual reports. ₩0 means no dividend that year.

Dividends & treasury shares

Treasury shares (FY2025): 3 shares (0.0% of shares issued)

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (separate) — view original ↗

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 2, 2026

Of 9 items: 1 met · 8 not met · 0 not computable

Not metMetNot computable

Positive net income

Whether net income (attributable to owners where available) is above zero.

Not met

-₩2.9B

Positive operating cash flow

Whether cash flow from operations is above zero.

Not met

-₩4.1B

Return on assets up

Whether net income over beginning total assets rose from the prior year.

Not met

3.0% → -1.0%

Operating cash flow exceeds net income

Whether operating cash flow is greater than net income.

Not met

-₩4.1B vs -₩2.9B

Liabilities-to-assets ratio down

Whether total liabilities as a share of total assets fell from the prior year.

Not met

53.9% → 57.6%

Current ratio up

Whether current assets over current liabilities rose from the prior year.

Not met

127.1% → 89.6%

Shares outstanding not increased

Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.

Met

5,485,962 → 5,485,962

Operating margin up

Whether operating income over revenue rose from the prior year.

Not met

6.4% → 2.3%

Asset turnover up

Whether revenue over beginning total assets rose from the prior year.

Not met

0.58x → 0.56x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (separate) — view original ↗

Grade change history

Jul 23, 2026D→C

Methodology version change (v2.0 applied)

Jul 15, 2026DVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Position within sector

1-year closing price

Financial strength

Growth momentum

Financial trend

Revenue

Growth & margin

Year over year — alongside the sector median

Price attractiveness

Shareholder Return

Dividend per share (annual)

Dividends & treasury shares

Financial checklist

Grade change history

Recent filings for this stock